At Optoceutics, we are committed to developing disease-modifying digital therapeutics (DTx) for neurodegenerative and psychological disorders such as Alzheimer’s, MCI, ADHD, and depression.
We work at the intersection of neuroscience, engineering and artificial intelligence to create preventive health solutions that are safe, non-invasive and drug-free.
Maximize your brain stimulation experience with OPTOINSIGHT ®
> Customize the brightness of the lamp
> Optimize the masked light according to your personal preferences
> Track your usage of the device
Optoceutics is currently conducting a clinical study to investigate the potential effect of masked 40 Hz flickering light on Alzheimer’s disease patients.
DISCLAIMER: All devices used in trials are considerd investigational devices and limited to investigational use only.
TV2 Lorry has followed us for a long time in connection with our participation in the Danish Tech Challenge.
